Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children

Launched by TASHKENT STATE MEDICAL UNIVERSITY (TASHKENT PEDIATRIC MEDICAL INSTITUTE), UZBEKISTAN · Feb 15, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and improving the treatment of common health issues in children, specifically respiratory diseases and congenital heart defects, in Uzbekistan. Researchers want to learn more about these conditions, how they affect children, and what current treatments are most effective. By doing this, they aim to develop better methods for treating and rehabilitating affected children.

The trial is open to children from birth up to 15 years old who live in the area where the study is taking place, particularly those who often get sick but do not have severe chronic illnesses. Participants will have their health monitored and may receive new treatment approaches designed to help them feel better. This is an important opportunity for children with specific health challenges to contribute to research that could improve their care and outcomes in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • children from birth to 15 years;
• • children permanently residing in the territory where the clinical examination is carried out;
• • children included in the group of "frequently ill children";
• • patients without severe chronic diseases.
• Exclusion Criteria:
• • Teenagers over 15 years old;
• • Patients with severe neurological and mental diseases;
• • Patients with endocrinological diseases;
• • Patients with long-term chronic somatic diseases;
• • Children without genetic pathologies.